Enexis AB

Type

Venture Capital

Status

Active

Location

Stockholm, Sweden

Total investments

6

Average round size

6M

Portfolio companies

4

Lead investments

1

Follow on index

0.33

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyInformation ServicesHealth CareMedicalMarketplacePharmaceuticalBiopharmaBioinformaticsCannabisAlternative Medicine

Investor highlights

Industry focus
Biotech/Life SciencesWellness & FitnessManufacturingCannabis
Stage focus
Series ASeries B
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 37 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
6
Lead investments
1
Follow on index
0.33
Investments by industry
  • Health Care (5)
  • Cannabis (5)
  • Alternative Medicine (2)
  • Marketplace (2)
  • Pharmaceutical (2)
  • Show 6 more
Investments by region
  • Germany (2)
  • United Kingdom (3)
  • Denmark (1)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
4
Group Appearance index
0.83

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Demecan 19 Dec 2022 Health Care, Medical, Pharmaceutical, Cannabis Early Stage Venture 17M Berlin, Berlin, Germany

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.